162 related articles for article (PubMed ID: 35326640)
61. Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase.
Takeda T; Tsubaki M; Kino T; Yamagishi M; Iida M; Itoh T; Imano M; Tanabe G; Muraoka O; Satou T; Nishida S
Chem Biol Interact; 2016 May; 251():26-33. PubMed ID: 26996543
[TBL] [Abstract][Full Text] [Related]
62. Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
Dietrich S; Krämer OH; Hahn E; Schäfer C; Giese T; Hess M; Tretter T; Rieger M; Hüllein J; Zenz T; Ho AD; Dreger P; Luft T
Clin Cancer Res; 2012 Jan; 18(2):417-31. PubMed ID: 22072733
[TBL] [Abstract][Full Text] [Related]
63. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
[TBL] [Abstract][Full Text] [Related]
64. Responsiveness of chronic lymphocytic leukemia cells to B-cell receptor stimulation is associated with low expression of regulatory molecules of the nuclear factor-κB pathway.
Meijers RWJ; Muggen AF; Leon LG; de Bie M; van Dongen JJM; Hendriks RW; Langerak AW
Haematologica; 2020 Jan; 105(1):182-192. PubMed ID: 31097630
[TBL] [Abstract][Full Text] [Related]
65. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
Zarnegar B; Yamazaki S; He JQ; Cheng G
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3503-8. PubMed ID: 18292232
[TBL] [Abstract][Full Text] [Related]
66. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
67. MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
Crassini K; Shen Y; Stevenson WS; Christopherson R; Ward C; Mulligan SP; Best OG
Br J Haematol; 2018 Aug; 182(3):360-372. PubMed ID: 29767411
[TBL] [Abstract][Full Text] [Related]
68. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
Demchenko YN; Glebov OK; Zingone A; Keats JJ; Bergsagel PL; Kuehl WM
Blood; 2010 Apr; 115(17):3541-52. PubMed ID: 20053756
[TBL] [Abstract][Full Text] [Related]
69. Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications.
Hideshima T; Chauhan D; Kiziltepe T; Ikeda H; Okawa Y; Podar K; Raje N; Protopopov A; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
Blood; 2009 May; 113(21):5228-36. PubMed ID: 19270264
[TBL] [Abstract][Full Text] [Related]
70. EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells.
Nabergoj S; Markovič T; Avsec D; Gobec M; Podgornik H; Jakopin Ž; Mlinarič-Raščan I
Biochem Pharmacol; 2021 Jan; 183():114352. PubMed ID: 33278351
[TBL] [Abstract][Full Text] [Related]
71. Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin.
Bednarski BK; Baldwin AS; Kim HJ
PLoS One; 2009 Sep; 4(9):e6992. PubMed ID: 19746155
[TBL] [Abstract][Full Text] [Related]
72. TNFSF14/LIGHT, a Non-Canonical NF-κB Stimulus, Induces the HIF Pathway.
D'Ignazio L; Batie M; Rocha S
Cells; 2018 Aug; 7(8):. PubMed ID: 30096845
[TBL] [Abstract][Full Text] [Related]
73. Thalidomide regulation of NF-κB proteins limits Tregs activity in chronic lymphocytic leukemia.
Skórka K; Bhattacharya N; Własiuk P; Kowal M; Mertens D; Dmoszyńska A; Giannopoulos K
Adv Clin Exp Med; 2014; 23(1):25-32. PubMed ID: 24596000
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells.
Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM
Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892
[TBL] [Abstract][Full Text] [Related]
75. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
76. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway.
Liu P; Li K; Garofalo RP; Brasier AR
J Biol Chem; 2008 Aug; 283(34):23169-78. PubMed ID: 18550535
[TBL] [Abstract][Full Text] [Related]
77. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
Mazzera L; Abeltino M; Lombardi G; Cantoni AM; Ria R; Ricca M; Saltarella I; Naponelli V; Rizzi FMA; Perris R; Corradi A; Vacca A; Bonati A; Lunghi P
Haematologica; 2019 Dec; 104(12):2465-2481. PubMed ID: 30948493
[TBL] [Abstract][Full Text] [Related]
78. Ethanol Decreases Inflammatory Response in Human Lung Epithelial Cells by Inhibiting the Canonical NF-kB-Pathway.
Mörs K; Hörauf JA; Kany S; Wagner N; Sturm R; Woschek M; Perl M; Marzi I; Relja B
Cell Physiol Biochem; 2017; 43(1):17-30. PubMed ID: 28848184
[TBL] [Abstract][Full Text] [Related]
79. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
[TBL] [Abstract][Full Text] [Related]
80. NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.
Noort AR; van Zoest KP; Weijers EM; Koolwijk P; Maracle CX; Novack DV; Siemerink MJ; Schlingemann RO; Tak PP; Tas SW
J Pathol; 2014 Nov; 234(3):375-85. PubMed ID: 25043127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
